TY  - JOUR
AU  - Caronna, E
AU  - José Gallardo, V
AU  - Alpuente, A
AU  - Torres-Ferrus, M
AU  - Sánchez-Mateo, N M
AU  - Viguera-Romero, J
AU  - López-Veloso, A C
AU  - López-Bravo, A
AU  - Gago-Veiga, A B
AU  - Irimia Sieira, P
AU  - Porta-Etessam, J
AU  - Santos-Lasaosa, S
AU  - Pozo-Rosich, P
AU  - Spanish CGRP-COVID Study Group
PY  - 2021
DO  - 10.1016/j.nrleng.2021.03.005
UR  - https://hdl.handle.net/10668/24374
T2  - Neurologia
AB  - CGRP, a neuropeptide involved in migraine pathophysiology, is also known to play a role in the respiratory system and in immunological conditions such as sepsis. We analyzed the impact of the use of CGRP antagonists in patients with migraine during...
LA  - en
KW  - Anticuerpos monoclonales
KW  - CGRP
KW  - COVID-19
KW  - Migraine
KW  - Migraña
KW  - Monoclonal antibodies
KW  - SARS-CoV-2
KW  - Antibodies, Monoclonal
KW  - COVID-19
KW  - Calcitonin Gene-Related Peptide
KW  - Cross-Sectional Studies
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Migraine Disorders
KW  - Pandemics
KW  - SARS-CoV-2
TI  - Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.
TY  - research article
VL  - 36
ER  -